| Name | Ethyl 4-(2-hydroxy-2-propanyl)-2-propyl-1-{[2'-(1-trityl-1H-tetra zol-5-yl)-4-biphenylyl]methyl}-1H-imidazole-5-carboxylate |
|---|---|
| Synonyms |
Ethyl 4-(2-hydroxy-2-propanyl)-2-propyl-1-{[2'-(1-trityl-1H-tetra zol-5-yl)-4-biphenylyl]methyl}-1H-imidazole-5-cboxylate
ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(N-triphenylmethyl-1H-tetrazole-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylate 1H-imidazole-5-cboxylic acid, 2-propyl-4-(1-hydroxy-1-methylethyl)-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-,ethyl ester ethyl 5-(1-hydroxy-1-methylethyl)-2-propyl-3-[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-3H-imidazole-4-carboxylate Trityl olMestan ethyl ester Azilstan medoxomil impurity229 OlMestan Ethyl Ester Trityl IMpurity Olmestan Ethyl Ester Trityl Impurity 1H-Imidazole-5-cboxylic acid, 4-(1-hydroxy-1-methylethyl)-2- propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'- biphenyl]-4-yl]methyl]-, ethyl ester' Ethyl 4-(1-hydroxy-1- methylethyl)-2-propyl-1-[4-[2-(trityltetrazol-5 ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5yl]biphenyl-4-yl]methyl]imidazole-5-carboxylate 4-(pyrrol-1-yl)benzoic acid ethyl ester ethyl 4-(pyrrol-1-yl)benzoate Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-(2(2-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)ethyl)-1H-imidazole-5-cboxylate ethyl 4-pyrrolylbenzoate OMSTINT-J 5-(4'-(dibromomethyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole Olmestan Medoxomil Impurity 28 4-(1-Hydroxy-1-methylethyl)-2-propyl-1[4-[2-(trityltetrazol-5-yl)phenyl]phenyl]methylimidazo-5-cboxylate ethyl 2-propyl-1-[[2'-[1-(triphenylMethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-, ethyl ester Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-cboxylate (Olmestan Medoxomi Impurity) ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityltetrazol-5-yl)-phenyl]phenyl}-methylimidazole-5-carboxylate Olmestan ester impurity 28 Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-cboxylate 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol 1-(4-ethoxycarbonylphenyl)pyrrole Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-cboxylate 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-cboxylic acid ethyl ester Olmestan Medoxomil Impurity 31 ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylate Olmestan Medoxomil-19 1H-Imidazole-5-cboxylic acid, 4-(1-hydroxy-1-methylethyl) 1H-IMidazole-5-cboxylic acid, 4-(1-hydroxy-1-Methylethyl)-2-propyl-1-[[2'-[1-(triphenylMethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-, ethyl ester 1H-IMidazole-5-cboxylic acid, 4-(1-hydroxy-1-Methylethyl)-2-propyl-1-[[2'-[1 ethyl 4-(1H-pyrrol-1-yl)benzoate Olmestan Medoxomil impurity 2/Olmestan Ethyl Ester Trityl Impurity/Ethyl 4-(2-Hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-cboxylate ethyl-4-(1-hydroxymethylethyl)-2-propyl-1-{4-(2-trityltetrazol-5-yl)phenyl}phenylmethylimidazole-5-carboxylate ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(1-trityltetrazol-5-yl)phenyl]phenylmethyl}imidazole-5-carboxylate |
| Molecular Formula | C45H44N6O3 |
|---|---|
| Molecular Weight | 716.86900 |
| Exact Mass | 716.34700 |
| PSA | 107.95000 |
| LogP | 8.44870 |
|
~91%
144690-33-5 |
| Literature: KRKA Patent: WO2007/17135 A2, 2007 ; Location in patent: Page/Page column 5; 21 ; |
| Precursor 2 | |
|---|---|
| DownStream 3 | |